Lv41
780 积分 2022-10-26 加入
Pd-L1 Expression and Egfr Status In Advanced Non-Small-Cell Lung Cancer Patients Receiving Pd-1/Pd-L1 Inhibitors: A Meta-Analysis
6小时前
已关闭
Differences in PD‐L1, PD‐L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study
7小时前
已关闭
Targeting cancer with small molecule pan-KRAS degraders
2天前
已完结
Molecular glues targeting GSPT1 in cancers: A potent therapy
3天前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
4天前
已完结
Exploring the next generation of antibody–drug conjugates
4天前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
7天前
已完结
PROTAC 2.0: Expanding the frontiers of targeted protein degradation
28天前
已完结
Perivascular Niche-Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment
1个月前
已完结
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
1个月前
已完结
皖公网安备34019202002308
